Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
AVDL —
AVADEL PHARMACEUTICALS PLC
CUSIP: G29687103 · Held by 2 superinvestors · Combined value: $26,054,640
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Ken Griffin | 0.0% | $20,158,560 | 935,432 | REDUCE | -368,854 |
| 2 | Jim Simons | 0.0% | $5,896,080 | 273,600 | REDUCE | -282,500 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | REDUCE | -282,500 | -50.8% |
| Ken Griffin | REDUCE | -368,854 | -28.3% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +302,500 | +119.3% |
| Ken Griffin | REDUCE | -401,031 | -23.5% |
Who Owns AVDL? Superinvestor Holdings
AVADEL PHARMACEUTICALS PLC is held by 2 tracked superinvestors, with a combined position value of $26 million . The largest positions are held by Ken Griffin (0.0% of portfolio), Jim Simons (0.0% of portfolio).
In the most recent quarter2 reduced or exited.